advances in multiple myeloma data highlights and analysis from the 2013 hematology conference

60
Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

Upload: shalom

Post on 06-Feb-2016

24 views

Category:

Documents


0 download

DESCRIPTION

Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference. Program Goals. Smoldering Multiple Myeloma High-Risk Disease. Concluding Remarks. References. References (cont). References (cont). References (cont). References (cont). References (cont). - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

Advances in Multiple MyelomaData Highlights and Analysis From the 2013

Hematology Conference

Page 2: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 3: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

Program Goals

Page 4: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

Smoldering Multiple MyelomaHigh-Risk Disease

Page 5: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 6: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 7: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 8: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 9: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 10: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 11: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 12: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 13: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 14: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 15: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 16: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 17: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 18: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 19: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 20: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 21: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 22: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 23: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 24: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 25: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 26: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 27: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 28: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 29: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 30: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 31: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 32: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 33: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 34: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 35: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 36: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 37: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 38: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 39: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 40: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 41: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 42: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 43: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 44: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 45: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 46: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 47: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 48: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

Concluding Remarks

Page 49: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

References

Page 50: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

References (cont)

Page 51: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

References (cont)

Page 52: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

References (cont)

Page 53: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

References (cont)

Page 54: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

References (cont)

Page 55: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

References (cont)

Page 56: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

References (cont)

Page 57: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference

References (cont)

Page 58: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 59: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference
Page 60: Advances in Multiple Myeloma Data Highlights and Analysis From the 2013 Hematology Conference